Camlin Fine Science Secures Regulatory Approvals for Majority Stake Acquisition in Vinpai
Reuters
Nov 26
Camlin Fine Science Secures Regulatory Approvals for Majority Stake Acquisition in Vinpai
Camlin Fine Science Limited (CFSL) has received all necessary Indian regulatory approvals for the issuance of new ordinary shares as consideration for acquiring a majority stake in Vinpai, a company specializing in algae- and plant-based functional ingredients for the food and cosmetics industries. On November 24, 2025, CFSL's board approved the allotment of these shares to the selling shareholders. The completion of this share allotment marks a significant step toward finalizing the acquisition, which is expected by the end of the month. Following the completion, CFSL will convert previously issued convertible bonds into ordinary shares of Vinpai and intends to launch a tender offer for the remaining shares at the same price paid in the initial acquisition.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vinpai SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20251125792218) on November 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.